Assessment of KAN-101 in Celiac Disease (ACeD)

NCT04248855 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: KAN-101
DRUG: Placebo

Sponsor

Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA